OBJECTIVE:Supported employment is the evidence-based treatment of choice for assisting individuals with severe mental illness to achieve competitive employment, but few supported employment programs specifically target older clients with psychiatric illness. The purpose of this study was to evaluate the efficacy of supported employment for middle-aged or older people with schizophrenia. METHOD:Participants included 58 outpatients with schizophrenia or schizoaffective disorder aged 45 or older who were recruited from a community mental health clinic. Participants were randomly assigned to receive Individual Placement and Support (IPS; the manualized version of supported employment) or conventional vocational rehabilitation (CVR) for one year, and completed assessments at baseline, six months, and twelve months. RESULTS: IPS was superior to CVR on nearly all work outcome measures, including attainment of competitive employment, weeks worked, and wages earned. Fifty-seven percent of IPS participants worked competitively, compared with 29% of CVR participants; 70% of IPS participants obtained any paid work, compared with 36% of CVR participants. Within the IPS group, better baseline functional capacity (as measured by the UCSD Performance Based Skills Assessment) and more recent employment were modestly associated with better work outcomes. CONCLUSIONS:Middle-aged and older adults with schizophrenia are good candidates for supported employment services. Published by Elsevier B.V.
RCT Entities:
OBJECTIVE: Supported employment is the evidence-based treatment of choice for assisting individuals with severe mental illness to achieve competitive employment, but few supported employment programs specifically target older clients with psychiatric illness. The purpose of this study was to evaluate the efficacy of supported employment for middle-aged or older people with schizophrenia. METHOD:Participants included 58 outpatients with schizophrenia or schizoaffective disorder aged 45 or older who were recruited from a community mental health clinic. Participants were randomly assigned to receive Individual Placement and Support (IPS; the manualized version of supported employment) or conventional vocational rehabilitation (CVR) for one year, and completed assessments at baseline, six months, and twelve months. RESULTS:IPS was superior to CVR on nearly all work outcome measures, including attainment of competitive employment, weeks worked, and wages earned. Fifty-seven percent of IPSparticipants worked competitively, compared with 29% of CVR participants; 70% of IPSparticipants obtained any paid work, compared with 36% of CVR participants. Within the IPS group, better baseline functional capacity (as measured by the UCSD Performance Based Skills Assessment) and more recent employment were modestly associated with better work outcomes. CONCLUSIONS: Middle-aged and older adults with schizophrenia are good candidates for supported employment services. Published by Elsevier B.V.
Authors: Brian Kirkpatrick; Erick Messias; Philip D Harvey; Emilio Fernandez-Egea; Christopher R Bowie Journal: Schizophr Bull Date: 2007-12-21 Impact factor: 9.306
Authors: David P Folsom; Colin Depp; Barton W Palmer; Brent T Mausbach; Shahrokh Golshan; Ian Fellows; Veronica Cardenas; Thomas L Patterson; Helena C Kraemer; Dilip V Jeste Journal: Schizophr Res Date: 2009-01-24 Impact factor: 4.939
Authors: Zanjbeel Mahmood; Amber V Keller; Cynthia Z Burton; Lea Vella; Georg E Matt; Susan R McGurk; Elizabeth W Twamley Journal: Psychiatr Serv Date: 2019-06-12 Impact factor: 3.084
Authors: Tomasz Zaprutko; Krzysztof Kus; Rostyslav Bilobryvka; Lyudmyla Rakhman; Robert Göder; Michał Michalak; Andrzej Pogłodziński; Elżbieta Nowakowska Journal: Psychiatr Q Date: 2015-12
Authors: Matthew J Smith; Emily J Ginger; Michael Wright; Katherine Wright; Laura Boteler Humm; Dale Olsen; Morris D Bell; Michael F Fleming Journal: J Nerv Ment Dis Date: 2014-09 Impact factor: 2.254
Authors: Yvonne B Suijkerbuijk; Frederieke G Schaafsma; Joost C van Mechelen; Anneli Ojajärvi; Marc Corbière; Johannes R Anema Journal: Cochrane Database Syst Rev Date: 2017-09-12
Authors: Jimmy Choi; Paul H Lysaker; Morris D Bell; Lisa Dixon; Paul Margolies; Matthew Gold; Elizabeth Golden-Roose; Warren Thime; Lawrence C Haber; Michael J Dewberry; Michael Stevens; Godfrey D Pearlson; Joanna M Fiszdon Journal: J Nerv Ment Dis Date: 2017-11 Impact factor: 2.254
Authors: Robert S Kern; Roberto Zarate; Shirley M Glynn; Luana R Turner; Kellie M Smith; Sharon S Mitchell; Catherine A Sugar; Morris D Bell; Robert P Liberman; Alex Kopelowicz; Michael F Green Journal: Schizophr Bull Date: 2018-01-13 Impact factor: 9.306